natgillin/translations-raw huggingface dataset:
convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness), lethargy (lack of energy and enthusiasm), tremor (involuntary trembling)
konvulzije, motnje ravnotežja, omotica (občutek nesigurnosti), letargija (pomanjkanje energije in navdušenja), tremor (nehoteno tresenje)
convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness), lethargy (lack of energy and enthusiasm), tremor (involuntary trembling);
konvulzije, motnje ravnotežja, omotica (občutek nesigurnosti), letargija (pomanjkanje energije in navdušenja), tremor (nehoteno tresenje)
convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness),lethargy (lack of energy and enthusiasm), tremor (involuntary trembling);
konvulzije, motnje ravnotežja, omotica (občutek nesigurnosti), letargija (pomanjkanje energije in navdušenja), tremor (nehoteno tresenje)
convulsion, balance disorder (equilibrium disorder),dizziness (sensation of unsteadiness), lethargy (lack of energy and enthusiasm), tremor (involuntary trembling);
konvulzije, motnje ravnotežja, omotica (občutek nesigurnosti), letargija (pomanjkanje energije in navdušenja), tremor (nehoteno tresenje)
Convulsion, balance disorder, dizziness, lethargy, tremor
konvulzije, motnje ravnotežja, omotica, letargija, tremor
Convulsion, clonus, brain oedema
konvulzije, klonus, možganski edem
Convulsion, febrile convulsion.
Konvulzija, vročinski krči
Convulsion, headache
konvulzije, glavobol
Convulsion, hypertonia, tremor, somnolence, headache, paraesthesia
konvulzije, hipertonija, tremor, somnolenca, glavobol, parestezija
Convulsion, hypertonia, tremor, somnolence, myasthenic syndrome, dizziness, headache, paraesthesia, dysgeusia
konvulzije, hipertonija, tremor, somnolenca, miastenijski sindrom, omotica, glavobol, parestezija, sprememba okusa
convulsion, neuropathy, hypoaesthesia, tremor
konvulzije, nevropatija, hipestezija, tremor
Convulsion, parosmia, hypokinesia, dysgraphia
konvulzije, parozmija, hipokinezija, disgrafija
convulsion, syncope, tremor, hypertonia3, paraesthesia, somnolence, dizziness
konvulzije, sinkopa, tremor, hipertonija3, parestezija, somnolenca, omotica
Convulsion, Tremor, Somnolence, Burning sensation
Konvulzije, tremor, somnolenca, pekoč občutek
Convulsion: narrow SMQ “Convulsions”
Konvulzije: zoženo standardizirano povpraševanje po Meddra (SMQ) „Konvulzije“
Convulsion^; Syncope; Dizziness ; Paraesthesia^;
Konvulzije^; sinkopa; omotica; parestezije^;
convulsione
omoticae, letargijae, konvulzijee
convulsions
epileptični napadi;
Convulsions (fits and seizures)
Konvulzije (krči in napadi)
convulsions (fits or seizures);
konvulzije (napade ali krče);
convulsions (fits or seizures);
konvulzije (napade krčev),
Convulsions (fits)
konvulzije (krči)
Convulsions (fits) linked to hypoglycaemia (abnormally low blood sugar levels),
krči, povezani s hipoglikemijo (neobičajno nizke revni sladkorja v krvi),
Convulsions (including febrile convulsions)
konvulzije (vključno s febrilnimi konvulzijami)
Convulsions (may affect up to 1 in 100 people) – convulsions (fits) are when a person's body shakes rapidly and uncontrollably.
Epileptični napadi (lahko se pojavijo pri največ 1 bolniku od 100 bolnikov) – pri epileptičnih napadih se bolnikovo telo hitro in nenadzorovano trese.
Convulsions (with or without fever)
konvulzije (z zvišano telesno temperaturo ali brez nje)
Convulsions and delirium, including altered level of consciousness
konvulzije in delirij, vključno s spremenjeno ravnijo zavesti,
Convulsions have been reported in patients receiving darbepoetin alfa in post-marketing experience (see section 4.4).
Pri bolnikih, ki so dobivali darbepoetin alfa, so v postmarketinškem obdobju poročali o konvulzijah (glejte poglavje 4.4).
Convulsions have been reported in patients receiving Nespo.
Pri bolnikih, ki so dobivali Nespo, so poročali o konvulzijah.
Convulsions or pronounced excitation: treat with benzodiazepines
konvulzije ali izrazito eksitacijo z benzodiazepini;
Convulsions were reported very commonly in the newly- diagnosed glioblastoma multiforme patients receiving monotherapy, and rash was reported very commonly in newly-diagnosed glioblastoma multiforme patients receiving TMZ concurrent with RT and also as monotherapy, and commonly in recurrent glioma.
Pri bolnikih z novo diagnosticiranim multiformnim glioblastomom na monoterapiji so zelo pogosto poročali o konvulzijah, medtem ko je bil izpuščaj opisan zelo pogosto pri bolnikih z novo diagnosticiranim multiformnim glioblastomom, ki so prejemali TMZ sočasno z RT, ter pri tistih, ki so zdravilo prejemali v obliki monoterapije, pogosto pa pri tistih s ponavljajočim se gliomom.
Convulsions with or without fever*
krči z zvišano telesno temperaturo ali brez nje
Convulsions with or without fever, occurring within 3 days of vaccination.
Krči z zvišano telesno temperaturo ali brez nje, ki se pojavijo v 3 dneh po cepljenju.
Convulsions with or without fever, occurring within 3 days of vaccination.
Krči z zvišano telesno temperaturo ali brez nje, ki so se pojavili v 3 dneh po cepljenju.
Convulsions with or without fever, occurring within 3 days.
Krči z zvišano telesno temperaturo ali brez nje, ki so se pojavili v 3 dneh.
Convulsions, chorea, myoclonia drowsiness, weakness, fatigue, headache
konvulzije, horea, mioklonija, zaspanost, šibkost, utrujenost, glavobol
Convulsions, consciousness decreased, somnolence, aphasia,
konvulzije, zmanjšana stopnja zavesti, somnolenca, afazija, poslabšano ravnotežje, omotica, zmedenost, poslabšanje spomina, poslabšanje koncentracije,
Convulsions, consciousness decreased, somnolence, aphasia, balance impaired, dizziness, confusion, memory impairment, concentration impaired, neuropathy, paraesthesia, speech disorder, tremor
konvulzije, motnje zavesti, somnolenca, afazija, motnje ravnotežja, omotica, zmedenost, motnje spomina, zmanjšanje miselne zbranosti, nevropatija, parestezije, motnje govora, tremor
Convulsions, consciousness decreased, somnolence, aphasia, balance impaired, dizziness, confusion, memory impairment, concentration impaired, neuropathy, paresthesia, speech disorder, tremor
konvulzije, motnje zavesti, somnolenca, afazija, motnje ravnotežja, omotica, zmedenost, motnje spomina, zmanjšanje miselne zbranosti, nevropatija, parestezije, motnje govora, tremor
Convulsions, consciousness decreased, somnolence, aphasia, balance impaired, dizziness, confusion, memory impairment, concentration impaired, neuropathy, paresthesia, speech disorder, tremor
konvulzije, zmanjšana zavest, somnolenca, afazija, slabše ravnotežje, omotica, zmedenost, slabši spomin, poslabšana zbranost, nevropatija, parestezija, motnje govora, tremor
Convulsions, eye swelling and anaphylaxis.
Krči, oteklost oči in anafilaksa
convulsions, fits or seizures fainting
konvulzije, napadi krčev ali epileptični napadi omedlevica
Convulsions, headache
konvulzije, glavobol
Convulsions, hypoaesthesia and tetany
konvulzije, hipestezija in tetanija (zaradi
Convulsions, increased tension in the muscles, shaking and muscle weakness, joint pain
Krči, povečana mišična napetost, tresenje, mišična šibkost, bolečine v sklepih.
Convulsions, nerve problems
epileptični krči, težave z živčevjem
Convulsions, nerve problems
epileptični krči, težave z živčevjem,
convulsions, neuropathy, hypoaesthesia, tremor, aphasia,
konvulzije, nevropatija, hipestezija, tremor, afazija,
Convulsions, parosmia, hypokinesia, dysgraphia
konvulzije, parozmija, hipokinezija, disgrafija
Convulsions, somnolence
konvulzije, somnolenca
Convulsions, sudden onset of sleep (see section 4.4), trismus, restless legs syndrome
konvulzije, nenaden nastop spanca (glejte poglavje 4.4), trizmus, sindrom nemirnih nog
Convulsions, syncope, transient ischaemic attack, unresponsiveness to stimuli, depressed level of consciousness, tremor, somnolence
konvulzije, sinkopa, tranzitorne ishemične atake, neodzivnost na spodbude, zmanjšana raven zavedanja, tremor, zaspanost
Convulsions.
Epileptični krči.
Convulsions.
konvulzije,
convulsions3, amnesia3, thinking abnormal3, ataxia3, coordination abnormal3, agitation3, tremor
konvulzije3, amnezija3, nenormalno mišljenje3, ataksija3, nenormalna koordinacija3, agitacija3, tremor
Cooling of the injection site, warming the injection liquid, use of cold packs (before and after the injection), and use of topical corticosteroids and antihistamines after the injection can alleviate the signs and symptoms of injection site reactions.
Hlajenje mesta injiciranja, segrevanje tekočine za injiciranje, uporaba hladnih obkladkov (pred in po injiciranju) in uporaba topikalnih kortikosteroidov in antihistaminikov po injiciranju lahko ublažijo znake in simptome reakcije na mestu injiciranja.
Cooling procedures such as ice packs should have been removed from the area at least 15 min before the Savene administration in order to allow sufficient blood flow.
Na tem področju je treba prenehati s postopki hlajenja, npr. z ledenimi obkladki, vsaj 15 minut pred dajanjem zdravila Savene, da se vzpostavi zadostna prekrvavitev.
Coombs
pozitiven
Coombs direct test positive, oxygen saturation decreased
pozitiven direktni Coombsov test, zmanjšana saturacija krvi s kisikom
Coombs test positive*
pozitivni Coombsov test
Coombs test positive, blood pressure systolic decreased, blood pressure systolic increased, body temperature increased
pozitivni Coombsov test, znižanje sistoličnega krvnega tlaka, zvišanje sistoličnega krvnega tlaka, zvišana telesna temperatura
Coombs test positive, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase
pozitiven Coombsov test, zvišanje serumske gama-glutamiltranspeptidaze (GGT), zvišanje serumske alkalne fosfataze
Coombs-negative anisocytosis and poikilocytosis were observed in rats, but not in mice or dogs.
Pri podganah so opažali Coombs-negativno anizocitozo in poikilocitozo, pri miših in psih pa ne.
Coombs` direct test positive (Coombs` test positive), decreased haemoglobin (including decreased haematocrit, decreased haptoglobin), increased alanine aminotransferase, increased blood lactate dehydrogenase, increased aspartate aminotransferase
pozitivni neposredni Coombsov test, (pozitivni Coombsov test), znižana koncentracija hemoglobina (vključno z zmanjšanim hematokritom, zmanjšanim haptoglobinom), povečana alanin-aminotransferaza, zvišanje ravni laktat-dehidrogenaze v krvi, povečana aspartat- aminotransferaza,
Coombs’ test positive, decreased haemoglobin (including decreased haematocrit, decreased haptoglobin), increased alanine aminotransferase, increased blood lactate dehydrogenase, increased aspartate aminotransferase).
Coombsov test pozitiven, znižana raven hemoglobina (vključno z zmanjšanim hematokritom, zmanjšanim haptoglobinom), zvišanje ravni alanin-aminotransferaze, zvišanje ravni laktatne dehidrogenaze v krvi, zvišanje aspartatne aminotransferaze).
Coombs’ test).
Coombsov test).
coordination
povečano
Coordination abnormal
motena koordinacija gibov
Coordination abnormal, memory impairment, amnesia, hypersomnia, sedation, aphasia, dysaesthesia, dystonia, lethargy, parosmia, cerebellar syndrome, convulsion, peripheral neuropathy, nystagmus, speech disorder, dysarthria, burning sensation, paresthesia, migraine
nenormalna koordinacija, motnje spomina, amnezija, hipersomnija, sedacija, afazija, disestezija, distonija, letargija, parozmija, cerebralni sindrom, napadi, periferna nevropatija, nistagmus, motnje govora, disartrija, pekoč občutek, parestezija, migrena
Coordination problems
težave v koordinaciji;
Copalia 5 mg/80 mg tablets are round and dark yellow with “NVR” on one side and “NV” on the other side.
Tablete zdravila Copalia 5 mg/80 mg so okrogle in temnorumene; na eni strani imajo oznako “NVR” in na drugi “NV”.
Copalia and older people (age 65 years or over)
Zdravilo Copalia in starejši ljudje (stari 65 let ali več)
Copalia can be used with or without food.
Bolnik lahko zdravilo Copalia vzame s hrano ali brez nje.
Copalia has not been studied in any patient population other than hypertension.
Zdravilo Copalia ni raziskano pri nobeni drugi populaciji, razen pri bolnikih s hipertenzijo.
Copalia HCT 10 mg/160 mg/12.5 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Copalia HCT 10 mg/160 mg/12,5 mg filmsko obložene tablete amlodipin/valsartan/hidroklorotiazid
Copalia HCT 10 mg/160 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Copalia HCT 10 mg/160 mg/25 mg filmsko obložene tablete amlodipin/valsartan/hidroklorotiazid
Copalia HCT 10 mg/320 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Copalia HCT 10 mg/320 mg/25 mg filmsko obložene tablete amlodipin/valsartan/hidroklorotiazid
Copalia HCT 5 mg/160 mg/12.5 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Copalia HCT 5 mg/160 mg/12,5 mg filmsko obložene tablete amlodipin/valsartan/hidroklorotiazid
Copalia HCT 5 mg/160 mg/12.5 mg film-coated tablets are white, oval tablets with “NVR” on one side and “VCL” on the other side.
Copalia HCT 5 mg/160 mg/12,5 mg filmsko obložene tablete so bele ovalne tablete z oznako “NVR” na eni strani in “VCL” na drugi.
Copalia HCT 5 mg/160 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Copalia HCT 5 mg/160 mg/25 mg filmsko obložene tablete amlodipin/valsartan/hidroklorotiazid
Copalia HCT is used to treat high blood pressure in adult patients whose blood pressure is already controlled while taking amlodipine, valsartan and hydrochlorothiazide and who may benefit from taking one tablet containing all three substances.
Zdravilo Copalia HCT uporabljamo za zdravljenje visokega krvnega tlaka pri odraslih bolnikih, pri katerih je krvni tlak že urejen, kadar jemljejo amlodipin, valsartan in hidroklorotiazid in bi jim ustrezalo jemanje ene same tablete, ki vsebuje vse tri zdravilne učinkovine.
Copalia HCT with food, drink and alcohol
Zdravilo Copalia HCT skupaj s hrano, pijačo in alkoholom
Copalia is contraindicated in patients with severe hepatic impairment (see section 4.3).
Pri bolnikih s hudo okvaro jeter je zdravilo Copalia kontraindicirano (glejte poglavje 4.3).
Copalia must not be used in patients who are hypersensitive (allergic) to amlodipine or other medicines in the ‘dihydropyridine derivatives’ class, to valsartan, or to any of the other ingredients.
Zdravila Copalia ne smejo uporabljati osebe, ki so preobčutljive za (alergične na) amlodipin ali druga zdravila iz razreda derivatov dihidropiridina, valsartan ali katero koli drugo sestavino zdravila.
COPD exacerbation data was collected in the 6- and 12–month pivotal studies.
Podatki o akutnih poslabšanjih KOPB so bili zbrani v dveh ključnih študijah: 6-mesečni in 12- mesečni.
COPD exacerbations
Akutna poslabšanja KOPB
COPD is a long- term condition in which the airways and air-sacs in the lungs gradually become blocked or damaged, leading to breathing difficulties that slowly get worse.
KOPB je dolgotrajna bolezen, pri kateri se postopoma razvija zapiranje ali okvara dihalnih poti in dihalnih mešičkov v pljučih; to povzroči težave z dihanjem, ki se počasi slabšajo.
COPD is a long-term disease and you should use this medicine every day and not only when you have breathing problems or other symptoms of COPD.
KOPB je dolgotrajna bolezen in to zdravilo morate uporabljati vsak dan, ne le takrat, ko težko dihate ali imate katerega od drugih simptomov KOPB.
COPD is a long-term disease and you should use Ultibro Breezhaler every day and not only when you have breathing problems or other symptoms of COPD.
KOPB je dolgotrajna bolezen in zdravilo Ultibro Breezhaler morate uporabljati vsak dan, ne le takrat, ko težko dihate ali imate katerega od drugih simptomov KOPB.
COPD is a long-term disease and you should use Ulunar Breezhaler every day and not only when you have breathing problems or other symptoms of COPD.
KOPB je dolgotrajna bolezen in zdravilo Ulunar Breezhaler morate uporabljati vsak dan, ne le takrat, ko težko dihate ali imate katerega od drugih simptomov KOPB.
COPD is a long-term disease and you should use Xoterna Breezhaler every day and not only when you have breathing problems or other symptoms of COPD.
KOPB je dolgotrajna bolezen in zdravilo Xoterna Breezhaler morate uporabljati vsak dan, ne le takrat, ko težko dihate ali imate katerega od drugih simptomov KOPB.
COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing air in and out of the lungs.
Kronična obstruktivna pljučna bolezen je dolgotrajna bolezen, pri kateri so dihalne poti in zračni mešički v pljučih poškodovani ali blokirani, kar povzroča težko vdihavanje in izdihavanje zraka.
COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing.
KOPB je kronična bolezen, pri kateri so dihalne poti in zračni mešički v pljučih poškodovani ali zamašeni, zaradi česar je dihanje oteženo.
COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing.
Kronična obstruktivna pljučna bolezen je dolgotrajna bolezen, pri kateri so dihalne poti in zračni mešički v pljučih poškodovani ali blokirani, zaradi česar je dihanje oteženo.
COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty in breathing.
Kronična obstruktivna pljučna bolezen je dolgotrajna bolezen, pri kateri so dihalne poti in zračni mešički v pljučih poškodovani ali blokirani, zaradi česar je dihanje oteženo.
COPD is a long-term disease; therefore, Brimica Genuair must be used every day, twice a day and not only when breathing problems or other symptoms of COPD are experienced.
KOPB je dolgotrajna bolezen, zato je potrebno zdravilo Brimica Genuair uporabljati vsak dan dvakrat na dan, in ne samo takrat, ko se pojavijo težave z dihanjem ali drugi simptomi KOPB.
COPD is a long-term disease; therefore, Duaklir Genuair must be used every day, twice a day and not only when breathing problems or other symptoms of COPD are experienced.
KOPB je dolgotrajna bolezen, zato je potrebno zdravilo Duaklir Genuair uporabljati vsak dan dvakrat na dan, in ne samo takrat, ko se pojavijo težave z dihanjem ali drugi simptomi KOPB.
COPD medicinal products
Zdravila za zdravljenje KOPB
Copies of the patient card to be given to patients before they receive Ruconest
opozorilno kartico za bolnika, ki jo mora bolnik prejeti pred začetkom jemanja zdravila Ruconest.
Copies of the patient card to be given to patients or caregivers before they receive Daxas
Kopije opozorilne kartice za bolnika, ki naj bi jih bolniki ali skrbniki prejeli pred začetkom jemanja zdravila Daxas
Copies of the patient card to be given to patients or caregivers before they receive Libertek
Kopije opozorilne kartice za bolnika, ki naj bi jih bolniki ali skrbniki prejeli pred začetkom jemanja zdravila Libertek
copies/ml)a
kopij/ml)a
copies/ml)§#
HIV-1/ml)§#
Copper-64 is a radioactive form of the chemical element copper, which emits the radiation needed for certain procedures that may be carried out on you.
Baker-64 je radioaktivna oblika kemijskega elementa baker, ki oddaja sevanje, potrebno za določene postopke, ki jih bodo morda opravili na vas.
Copper-releasing intrauterine devices are generally not recommended due to the potential risks of infection at the time of insertion and menstrual blood loss which may compromise patients with neutropenia or thrombocytopenia.
Intrauterini vložki, ki sproščajo baker, na splošno niso priporočljivi zaradi možnega tveganja za nastanek okužb ob času vstavitve in izgubo krvi med menstruacijo kar lahko ogrozi bolnice z nevtropenijo ali trombocitopenijo.
cor pulmonale, myocarditis, acute coronary syndrome, cardiac arrest, electrocardiogram PR prolongation, coronary artery disease, pleuropericarditis
pljučno srce, miokarditis, akutni koronarni sindrom, srčni zastoj, podaljšanje intervala PR na elektrokardiogramu, koronarna arterijska bolezen, plevroperikarditis
Corbilta 100 mg/25 mg/200 mg film-coated tablets
Corbilta 100 mg/25 mg/200 mg filmsko obložene tablete
Corbilta 100 mg/25 mg/200 mg: brownish or greyish red, oval, unscored film-coated tablets marked with ‘LCE 100’ on one side.
Zdravilo Corbilta 100 mg/25 mg/200 mg so rjavkaste ali sivkasto-rdečkaste filmsko obložene ovalne tablete brez zareze, z oznako »LCE 100« na eni strani.
Corbilta 125 mg/31.25 mg/200 mg film-coated tablets
Corbilta 125 mg/31,25 mg/200 mg filmsko obložene tablete
Corbilta 125 mg/31.25 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Corbilta 125 mg/31,25 mg/200 mg filmsko obložene tablete levodopa/karbidopa/entakapon
Corbilta 125 mg/31.25 mg/200 mg: light brownish red, oval film-coated tablets marked with ‘LCE 125’ on one side.
Zdravilo Corbilta 125 mg/31,25 mg/200 mg: svetlorjavkasto rdeče, ovalne tablete z oznako »LCE 125« na eni strani.
Corbilta 150 mg/37.5 mg/200 mg film-coated tablets
Corbilta 150 mg/37,5 mg/200 mg filmsko obložene tablete
Corbilta 150 mg/37.5 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Corbilta 150 mg/37,5 mg/200 mg filmsko obložene tablete levodopa/karbidopa/entakapon
Corbilta 150 mg/37.5 mg/200 mg: brownish or greyish red, elongated-ellipse shaped, unscored film- coated tablets marked with ‘LCE 150’ on one side.
Zdravilo Corbilta 150 mg/37,5 mg/200 mg so rjavkaste ali sivkasto-rdeče, podolgovate filmsko obložene tablete v obliki elipse brez zareze, z oznako »LCE 150« na eni strani.
Corbilta 175 mg/43.75 mg/200 mg film-coated tablets
Corbilta 175 mg/43,75 mg/200 mg filmsko obložene tablete
Corbilta 175 mg/43.75 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Corbilta 175 mg/43,75 mg/200 mg filmsko obložene tablete levodopa/karbidopa/entakapon
Corbilta 175 mg/43.75 mg/200 mg: light brownish red, oval, unscored film-coated tablets marked with ‘LCE 175’ on one side.
Zdravilo Corbilta 175 mg/43,75 mg/200 mg: svetlorjavkasto rdeče, ovalne tablete z oznako »LCE 175« na eni strani.
Corbilta 200 mg/50 mg/200 mg film-coated tablets
Corbilta 200 mg/50 mg/200 mg filmsko obložene tablete
Corbilta 200 mg/50 mg/200 mg: dark brownish red, oval, unscored film-coated tablets marked with ‘LCE 200’ on one side.
Zdravilo Corbilta 200 mg/50 mg/200 mg: temno rjavo-rdeče ovalne filmsko obložene tablete brez zareze z oznako „LCE 200“ na eni strani.
Corbilta 50 mg/12.5 mg/200 mg film-coated tablets
Corbilta 50 mg/12,5 mg/200 mg filmsko obložene tablete
Corbilta 50 mg/12.5 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Corbilta 50 mg/12,5 mg/200 mg filmsko obložene tablete levodopa/karbidopa/entakapon
Corbilta 50 mg/12.5 mg/200 mg: brownish or greyish red, round, convex unscored film-coated tablets marked with ‘LCE 50’ on one side.
Zdravilo Corbilta 50 mg/12,5 mg/200 mg so rjavkaste ali sivkasto-rdeče, okrogle, konveksne filmsko obložene tablete brez zareze, z oznako »LCE 50« na eni strani.
Corbilta 75 mg/18.75 mg/200 mg film-coated tablets
Corbilta 75 mg/18,75 mg/200 mg filmsko obložene tablete
Corbilta 75 mg/18.75 mg/200 mg: light brownish red, oval film-coated tablets marked with ‘LCE 75’ on one side.
Zdravilo Corbilta 75 mg/18,75 mg/200 mg: svetlorjavkasto rdeče, ovalne filmsko obložene tablete z oznako »LCE 75« na eni strani.
Corbilta contains sucrose, and therefore patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Zdravilo Corbilta vsebuje saharozo, zato bolniki z redkimi prirojenimi motnjami, kot so intoleranca za fruktozo, malabsorpcija glukoze-galaktoze ali pomanjkanje saharaze-izomaltaze, ne smejo jemati tega zdravila.
Corbilta contains three active substances (levodopa, carbidopa and entacapone) in one film-coated tablet.
Zdravilo Corbilta vsebuje tri zdravilne učinkovine (levodopo, kabidopo in entakapon) v eni filmsko obloženi tableti.
Corbilta is available as a range of tablets in seven strengths, containing 50 to 200 mg levodopa and to 50 mg carbidopa.
Zdravilo Corbilta je na voljo v obliki tablet v sedmih jakostih, ki vsebujejo od 50 do 200 mg levodope in od 12,5 do 50 mg karbidope.